Digital Oncology

Patients now understand the risk numbers perfectly, yet anxiety still drives them to choose preventive surgery A new study examining genetic counseling reveals a complex gap between understanding statistics and making medical decisions. Researchers tested a visual aid designed to help breast cancer patients understand their specific risk of developing cancer in the opposite breast. While the tool successfully improved the patients accuracy in estimating their numerical risk it surprisingly had little impact on their actual choices. Many women still opted for preventive mastectomies driven by anxiety and a desire for symmetry rather than the medical data itself. This finding highlights that clinical decision making is deeply emotional and cannot be swayed by numbers alone. It suggests that future counseling tools must address psychological factors and personal fears just as much as they address statistical probabilities to truly support patients in making informed choices. Read the ...

 Radiation therapy is a cornerstone of cancer treatment but it often causes severe collateral damage to the lungs known as radiation induced lung injury or RILI. To better understand and prevent this researchers are moving beyond animal models to use advanced lung on a chip technology. These microfluidic devices simulate the breathing motions and cellular structure of human lung tissue allowing scientists to observe exactly how radiation damages cells at a molecular level. The study is using these chips to test new therapies including antifibrotic drugs that could protect healthy lung tissue during cancer treatment. By providing a highly accurate model of human physiology this technology allows for the rapid screening of potential protective agents bringing us closer to a future where cancer can be irradiated without permanently scarring the patients lungs. Read the original article at: https://www.nature.com/articles/s41598-025-31582-1   Follow us on Instagram , Twit...

 In a promising breakthrough for pediatric cancer researchers have used machine learning to identify a potent new treatment using drugs that are already on pharmacy shelves. The study focused on neuroblastoma a childhood cancer that is notoriously resistant to chemotherapy. By analyzing vast datasets of gene interactions the AI identified that combining statins used for cholesterol with phenothiazines used for migraines creates a deadly effect on tumor cells. This specific drug cocktail works by disrupting the cancer cells ability to manage lipids causing them to die while leaving healthy cells relatively unharmed. In mouse models this combination significantly slowed tumor growth and extended survival. This research highlights the immense potential of drug repurposing where artificial intelligence can uncover life saving uses for existing safe medications without the decade long timeline of developing new drugs from scratch. Read the original article at: https://medicalxpress.c...

 A critical analysis of cancer care delivery argues that the current system of waiting time targets is outdated and dangerously misleading. The report warns that benchmarks such as the 62 day referral to treatment target are frequently missed and fail to capture the reality of modern complex care pathways. Patients who require multiple diagnostic tests or specialized scans often face delays that are invisible in the official data yet these delays significantly increase mortality risks. The authors contend that the increasing complexity of cancer cases combined with a lack of investment in staff and facilities has created a crisis that simple targets cannot fix. They call for a systemic overhaul involving a national learning system that uses real time data to identify bottlenecks and prioritize patients based on clinical urgency rather than arbitrary administrative clocks. Read the original article at: http://www.bmj.com/content/392/bmj.s14.short?rss=1 Follow us on Instagram , ...

 A new study examining genetic counseling reveals a complex gap between understanding statistics and making medical decisions. Researchers tested a visual aid designed to help breast cancer patients understand their specific risk of developing cancer in the opposite breast. While the tool successfully improved the patients accuracy in estimating their numerical risk it surprisingly had little impact on their actual choices. Many women still opted for preventive mastectomies driven by anxiety and a desire for symmetry rather than the medical data itself. This finding highlights that clinical decision making is deeply emotional and cannot be swayed by numbers alone. It suggests that future counseling tools must address psychological factors and personal fears just as much as they address statistical probabilities to truly support patients in making informed choices. Read the original article at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843738 Follow us on Ins...

  Mount Sinai’s new AI replaces weeks of manual review, scanning records in real-time to find trial patients instantly. A leading cancer center in New York has deployed a specialized artificial intelligence platform to solve the persistent problem of low enrollment in clinical trials. The system uses a large language model trained specifically on oncology data to scan electronic health records in real time. Unlike general AI tools this model understands complex cancer terminology including specific biomarkers and treatment histories hidden in unstructured doctor notes. By automating the screening process the technology identifies eligible patients the moment they qualify replacing the slow and fragmented manual review that often causes patients to miss out on experimental therapies. Clinicians report that the tool drastically reduces the administrative burden allowing them to focus on discussing meaningful treatment options with patients rather than sifting through paperwork. This ...

 The gene editing tool CRISPR has fundamentally transformed cancer research by acting as molecular scissors that can cut and modify DNA with unprecedented ease. Since its introduction the technology has allowed scientists to deactivate specific genes or introduce new DNA sequences much faster and cheaper than older methods allowed. This efficiency is accelerating the development of next generation therapies including CAR T cells that are engineered to hunt down cancer more effectively. Researchers are currently using the tool to create more accurate mouse models of human cancer and to identify the genetic drivers of tumor growth. While challenges remain regarding how to deliver the tool safely into the human body without affecting healthy cells the technology offers a promising path toward treating cancer at its genetic root rather than just managing symptoms. Read the original article at: https://www.cancer.gov/news-events/cancer-currents-blog/2020/crispr-cancer-research-treatm...

 For patients with inoperable lung cancer radiofrequency ablation offers a lifeline but its success depends heavily on the precise placement of needles. A new study demonstrates that using robotic assistance can significantly improve the safety and efficiency of this delicate procedure. Researchers compared standard manual techniques against a robot guided system that uses artificial intelligence for real time motion tracking. The results showed that the robot helped doctors position the probe with far greater accuracy while reducing the time needed for needle insertion by several minutes. Most importantly the robotic approach cut the duration of CT scans and the resulting radiation exposure to the patient by nearly fifty percent. This finding suggests that integrating robotics into interventional radiology not only standardizes outcomes but also protects vulnerable patients from unnecessary radiation risks during treatment. Read the original article at: https://radiologybusines...

 A critical new analysis argues that current targets for cancer treatment waiting times are failing patients and obscuring the true extent of delays. The report highlights that arbitrary benchmarks such as the 62 day target from referral to treatment are frequently missed and do not account for the increasing complexity of modern cancer care. Patients requiring multiple diagnostic tests often face much longer waits that are not accurately reflected in official data. These delays are not merely administrative nuisances they significantly increase the risk of mortality.  The authors contend that simply setting stricter targets is ineffective without addressing the underlying lack of resources. Instead they call for a national learning system driven by data and collaboration to identify bottlenecks in real time and prioritize patients based on clinical urgency rather than outdated metrics. Read the original article at: http://www.bmj.com/content/392/bmj.s14.short?rss=1 Follow ...

 A leading cancer center in New York has deployed a specialized artificial intelligence platform to solve the persistent problem of low enrollment in clinical trials. The system uses a large language model trained specifically on oncology data to scan electronic health records in real time. Unlike general AI tools this model understands complex cancer terminology including specific biomarkers and treatment histories hidden in unstructured doctor notes. By automating the screening process the technology identifies eligible patients the moment they qualify replacing the slow and fragmented manual review that often causes patients to miss out on experimental therapies. Clinicians report that the tool drastically reduces the administrative burden allowing them to focus on discussing meaningful treatment options with patients rather than sifting through paperwork. This deployment marks a significant step toward making access to advanced cancer research faster and more equitable. Read ...

Recovery, reimagined. Mobile health coaching significantly improves quality of life for post-gastrectomy patients. A randomized clinical trial explores the potential of digital therapeutics in recovering from major cancer surgery. The study focused on patients who had undergone gastrectomy for gastric cancer, a procedure that often requires strict lifestyle adjustments. Researchers introduced a mobile app that provided interactive "human coaching" to guide patients through their recovery. While the app didn't drastically change eating habits in the critical first month, the long-term benefits were clear. Active users of the app reported significantly better "global health status" and fewer issues with dyspnea (shortness of breath) at the 3-month and 6-month marks compared to those receiving standard care. Perhaps most importantly for oncology patients, the digital intervention helped reduce negative body image issues, suggesting that the psychological support pr...

 A disturbing study from Harvard Medical School has uncovered a "hidden" bias in AI models used for cancer diagnosis. The research found that deep learning algorithms, when trained on medical images like pathology slides, can learn to identify a patient's self-reported race—a feat human doctors cannot do from images alone. The problem arises when the AI uses this racial data as a "shortcut" to make diagnostic predictions, rather than relying solely on biological disease markers. The study revealed that in nearly 30% of the tested tasks, the AI models exhibited significant performance disparities, often yielding less accurate results for Black patients due to imbalances in the training data. This "algorithmic racism" could lead to misdiagnoses and unequal care if left unchecked. The researchers are calling for a new training approach, proposing a method called "FAIR-Path" that explicitly prevents models from relying on demographic shortcuts,...

 Patients with dermatomyositis (DM) face a significantly higher risk of developing cancer, but identifying which patients are most vulnerable has historically been difficult. A new study has developed the "TIP-CA" clinical score, a precision tool designed to solve this puzzle. Validated in a cohort of over 500 adults, the model analyzes five specific risk factors: anti-TIF1-gamma antibody status, the presence of poikiloderma (skin discoloration), anemia, disease subtype, and lung involvement. The results showed that patients with a high TIP-CA score (4-5) had a very high likelihood of concurrent cancer, allowing doctors to stratify risk with much greater confidence. A cutoff score of 2.5 was found to offer the best balance of sensitivity and specificity. This simple yet robust scoring system provides rheumatologists and oncologists with a practical method to screen high-risk patients earlier, potentially catching malignancies at a treatable stage when they might otherwise ...

 Radiologists may soon have a powerful new standard for evaluating soft-tissue tumors. A study detailed in Radiology Business introduces "ST-RADS" (Soft-Tissue Tumor Reporting and Data System), a structured MRI scoring framework designed to replace the often vague descriptive reports currently in use. In a validation study involving roughly 200 patients, the ST-RADS system demonstrated exceptional precision, achieving a 99.2% accuracy rate in predicting malignancy—significantly outperforming the 92.8% accuracy of standard radiological reports. Crucially, the system was perfect (100% accuracy) in identifying benign tumors, a capability that could drastically reduce unnecessary biopsies and patient anxiety. By standardizing how these complex images are interpreted, ST-RADS offers a clear, objective roadmap for clinicians, ensuring that aggressive cancers are flagged immediately while harmless lumps are safely monitored without invasive intervention. Read the original artic...

A randomized clinical trial explores the potential of digital therapeutics in recovering from major cancer surgery. The study focused on patients who had undergone gastrectomy for gastric cancer, a procedure that often requires strict lifestyle adjustments. Researchers introduced a mobile app that provided interactive "human coaching" to guide patients through their recovery. While the app didn't drastically change eating habits in the critical first month, the long-term benefits were clear. Active users of the app reported significantly better "global health status" and fewer issues with dyspnea (shortness of breath) at the 3-month and 6-month marks compared to those receiving standard care. Perhaps most importantly for oncology patients, the digital intervention helped reduce negative body image issues, suggesting that the psychological support provided by the app was just as valuable as the physical guidance. The findings support the integration of mobile coa...